Trade Vaxcyte Inc - PCVX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.22 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 37.7 |
| Open | 37.47 |
| 1-Year Change | -45.09% |
| Day's Range | 32.51 - 37.47 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 37.70 | 4.97 | 15.18% | 32.73 | 37.86 | 30.03 |
| Mar 28, 2025 | 69.37 | -0.83 | -1.18% | 70.20 | 71.00 | 68.32 |
| Mar 27, 2025 | 70.66 | 1.87 | 2.72% | 68.79 | 71.41 | 68.30 |
| Mar 26, 2025 | 68.50 | -1.45 | -2.07% | 69.95 | 70.87 | 68.34 |
| Mar 25, 2025 | 71.85 | -1.62 | -2.20% | 73.47 | 73.47 | 71.07 |
| Mar 24, 2025 | 73.66 | -1.15 | -1.54% | 74.81 | 74.87 | 72.84 |
| Mar 21, 2025 | 74.55 | 2.51 | 3.48% | 72.04 | 76.37 | 72.04 |
| Mar 20, 2025 | 74.41 | -0.65 | -0.87% | 75.06 | 76.13 | 73.46 |
| Mar 19, 2025 | 76.04 | 2.59 | 3.53% | 73.45 | 76.30 | 73.45 |
| Mar 18, 2025 | 74.68 | -0.05 | -0.07% | 74.73 | 74.73 | 73.00 |
| Mar 17, 2025 | 75.05 | 1.10 | 1.49% | 73.95 | 75.77 | 73.44 |
| Mar 14, 2025 | 74.26 | 0.34 | 0.46% | 73.92 | 74.79 | 72.81 |
| Mar 13, 2025 | 72.99 | 1.30 | 1.81% | 71.69 | 75.85 | 71.61 |
| Mar 12, 2025 | 73.17 | 3.21 | 4.59% | 69.96 | 74.82 | 69.91 |
| Mar 11, 2025 | 69.69 | 1.65 | 2.43% | 68.04 | 70.09 | 67.21 |
| Mar 10, 2025 | 68.69 | -2.55 | -3.58% | 71.24 | 71.24 | 68.25 |
| Mar 7, 2025 | 71.12 | -2.32 | -3.16% | 73.44 | 74.83 | 71.06 |
| Mar 6, 2025 | 74.76 | 2.49 | 3.45% | 72.27 | 76.24 | 71.01 |
| Mar 5, 2025 | 73.84 | 3.48 | 4.95% | 70.36 | 74.00 | 69.55 |
| Mar 4, 2025 | 70.18 | -1.03 | -1.45% | 71.21 | 71.89 | 69.31 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Vaxcyte, Inc. Company profile
About Vaxcyte Inc
Vaxcyte Inc. is a vaccine company, which is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes VAX-24, VAX-XP, VAX-A1 and VAX-PG. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine (PCV). The Company's second PCV candidate, VAX-XP, uses its modular platform and builds on the technical proof of concept established by VAX-24. VAX-A1 is a conjugate vaccine being developed for group A strep infections. Its VAX -PG is being developed as a protein vaccine for the treatment of periodontitis.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vaxcyte Inc revenues was not reported. Net loss increased 12% to $100.1M. Higher net loss reflects General and administrative - Balancing increase of 49% to $18.5M (expense), Stock-based Compensation in SGA increase of 90% to $6.8M (expense), Stock-based Compensation in R&D increase from $1.9M to $4M (expense).
| Industry: | Bio Therapeutic Drugs |
825 Industrial Road, Ste. 300
SAN CARLOS
CALIFORNIA 94070
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com